ABCAM Plc Total Voting Rights (7606K)
January 04 2016 - 10:02AM
UK Regulatory
TIDMABC
RNS Number : 7606K
ABCAM Plc
04 January 2016
For immediate release 4 January 2016
ABCAM PLC
("Abcam" or "Company")
Total Voting Rights - Voting Rights and Capital
In conformity with the Disclosure Rules and Transparency Rules,
provision 5.6.1, the Company notifies the market of the
following:
The Company's issued share capital consists of 202,320,727
Ordinary Shares of 0.2p each with voting rights. The Company does
not hold any shares in Treasury.
The above figure of 202,320,727 may be used by shareholders as
the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change to
their interest in the Company under the FCA's Disclosure and
Transparency Rules.
Date of Notification: 4 January 2016
For further information please contact:
+ 44 (0) 1223
Abcam 696 000
Suzanne Smith, Company Secretary
J.P.Morgan Cazenove - Nominated + 44 (0) 20
Adviser & Corporate Broker 7742 4000
James Mitford / Alex Bruce - Nominated
Adviser
Notes to Editors
About Abcam
Abcam plc is a global leader in the supply of life science
research tools, with a wide range of products and expert technical
support, enabling scientists to analyse living cells at the
molecular level and improving the understanding of health and
disease.
Abcam is committed to providing scientists with an extensive
choice of reagents and tools, with the most comprehensive, honest
and up-to-date datasheets and customer reviews, fast delivery and
helpful customer service & technical support. The Company's
catalogue evolves with scientific research trends and is growing
each year to provide customers with products to meet their research
needs. The range now includes primary and secondary antibodies,
proteins, peptides, lysates, biochemicals, immunoassays and other
kits. Abcam also supports its customers by hosting a range of
global scientific events, forums and webinars, providing
opportunities for scientists to get together and present their
work.
Headquartered in Cambridge, UK, Abcam has nine global subsidiary
offices enabling local services and multi-language support and
sells to over 130 countries. The Company was founded in 1998, and
now employs over 820 people. Abcam was admitted to AIM in 2005
(AIM: ABC).
To find out more, please visit www.abcam.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRUGURAGUPQGCC
(END) Dow Jones Newswires
January 04, 2016 10:02 ET (15:02 GMT)
Abcam (LSE:ABC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Abcam (LSE:ABC)
Historical Stock Chart
From Mar 2023 to Mar 2024